Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review
Yıl: 2021 Cilt: 5 Sayı: 4 Sayfa Aralığı: 491 - 495 Metin Dili: İngilizce DOI: 10.14744/ejmi.2021.30687 İndeks Tarihi: 18-05-2022
Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review
Öz: Objectives: Adenoid cystic carcinoma (ACC) is a rare tumor that arises from the salivary glands. Since it is rare, there are no consensus recommendations on its treatment strategy. Surgery, radiotherapy (RT), and systemic treatments are options We aimed to evaluate the treatment outcomes and prognostic factors in ACC. Methods: In this retrospective study; 17 ACC patients were included who were diagnosed with between January 2005 and April 2020 in Karadeniz Technical University Faculty of Medicine. We analyzed the demographic data of these 17 patients, effects of inflammatory markers on overall survival (OS) and progression-free survival (PFS). Results: Ten women and seven men were included in this study. At the diagnosis, 6 patients were metastatic, 5 of them had received chemotherapy. There was no statistical difference in overall survival according to neutrophil/lymphocyte ratio (N/L) and platelet/lymphocyte (T/L) ratio. Conclusion: Primary surgery is the most effective treatment, If possible, metastasectomy should be performed. ACC is a chemotherapy-resistant disease, so chemotherapy should only be given to metastatic, symptomatic, and fıt patients. We did not detect the prognostic effect of T/L and N/L in a limited number of ACC samples.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
- 1. Ellington CL, Goodman M, Kono SA, Grist W, Wadsworth T, Chen AY, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 surveillance, epidemiology, and end results data. Cancer 2012;118:4444–51.
- 2. Demircan V, Akmansu M, Aydil U, Türkcan A, Au D, Sayar E. Sin- gle institutional experience of head and neck adenoid cystic carcinomas. Otorhinolaryngol Head Neck Surg 2018;3:2–4.
- 3. Park I, Lim SN, Dok HY, Park H, Sun B, Pil HL, et al. Metastasec- tomy for hepatic metastases from adenoid cystic carcinoma of the trachea. Gut Liver 2009;3:127–9.
- 4. Liu D, Labow DM, Dang N, Martini N, Bains M, Burt M, et al. Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol 1999;6:572–8.
- 5. Mimica X, McGill M, Hay A, Karassawa Zanoni D, Shah JP, Wong RJ, et al. Distant metastasis of salivary gland cancer: Incidence, management, and outcomes. Cancer 2020;126:2153–62.
- 6. Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 2011;12:815–24.
- 7. Mannelli G, Cecconi L, Fasolati M, Santoro R, Franchi A, Gallo O. Parotid adenoid cystic carcinoma: Retrospective single in- stitute analysis. Am J Otolaryngol 2017;38:394–400.
- 8. Brkic FF, Kadletz L, Jank B, Cede J, Seemann R, Schneider S, et al. Pretreatment assessment of hematologic and inflammato- ry markers in adenoid cystic carcinoma: neutrophil/lympho- cyte ratio is associated with multiple recurrences. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:408–16.
- 9. Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Ade- noid cystic carcinoma of the head and neck - A 20 years expe- rience. Int J Oral Maxillofac Surg 2004;33:25–31.
- 10. Amit M, Na’ara S, Trejo–Leider L, Ramer N, Burstein D, Yue M, et al. Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study. Head Neck 2017;39:1008–14.
- 11. Tirelli G, Capriotti V, Sartori G, Tofanelli M, Marcuzzo AV. Prima- ry adenoid cystic carcinoma of the frontal sinus: case descrip- tion of a previously unreported entity and literature review. Ear Nose Throat J 2019;98:E8–12.
- 12. Turri–Zanoni M, Salzano G, Lambertoni A, Giovannardi M, Kar- ligkiotis A, Battaglia P, et al. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutro- phil-to-lymphocyte and platelet-to-lymphocyte ratio. Head Neck 2017;39:730–6.
- 13. Chae YK, Chung SY, Davis AA, Carneiro BA, Chandra S, Kaplan J, et al. Adenoid cystic carcinoma: Current therapy and poten- tial therapeutic advances based on genomic profiling. Onco- target 2015;6:37117–34.
| APA | ALANDAG C, KAZAZ S, COBANOGLU B (2021). Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. , 491 - 495. 10.14744/ejmi.2021.30687 |
| Chicago | ALANDAG Celal,KAZAZ Seher Nazli,COBANOGLU Bengu Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. (2021): 491 - 495. 10.14744/ejmi.2021.30687 |
| MLA | ALANDAG Celal,KAZAZ Seher Nazli,COBANOGLU Bengu Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. , 2021, ss.491 - 495. 10.14744/ejmi.2021.30687 |
| AMA | ALANDAG C,KAZAZ S,COBANOGLU B Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. . 2021; 491 - 495. 10.14744/ejmi.2021.30687 |
| Vancouver | ALANDAG C,KAZAZ S,COBANOGLU B Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. . 2021; 491 - 495. 10.14744/ejmi.2021.30687 |
| IEEE | ALANDAG C,KAZAZ S,COBANOGLU B "Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review." , ss.491 - 495, 2021. 10.14744/ejmi.2021.30687 |
| ISNAD | ALANDAG, Celal vd. "Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review". (2021), 491-495. https://doi.org/10.14744/ejmi.2021.30687 |
| APA | ALANDAG C, KAZAZ S, COBANOGLU B (2021). Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. Eurasian Journal of Medical Investigation, 5(4), 491 - 495. 10.14744/ejmi.2021.30687 |
| Chicago | ALANDAG Celal,KAZAZ Seher Nazli,COBANOGLU Bengu Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. Eurasian Journal of Medical Investigation 5, no.4 (2021): 491 - 495. 10.14744/ejmi.2021.30687 |
| MLA | ALANDAG Celal,KAZAZ Seher Nazli,COBANOGLU Bengu Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. Eurasian Journal of Medical Investigation, vol.5, no.4, 2021, ss.491 - 495. 10.14744/ejmi.2021.30687 |
| AMA | ALANDAG C,KAZAZ S,COBANOGLU B Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. Eurasian Journal of Medical Investigation. 2021; 5(4): 491 - 495. 10.14744/ejmi.2021.30687 |
| Vancouver | ALANDAG C,KAZAZ S,COBANOGLU B Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review. Eurasian Journal of Medical Investigation. 2021; 5(4): 491 - 495. 10.14744/ejmi.2021.30687 |
| IEEE | ALANDAG C,KAZAZ S,COBANOGLU B "Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review." Eurasian Journal of Medical Investigation, 5, ss.491 - 495, 2021. 10.14744/ejmi.2021.30687 |
| ISNAD | ALANDAG, Celal vd. "Adenoid Cystic Carcinoma; A Single Center 15 Years Experience and Literature Review". Eurasian Journal of Medical Investigation 5/4 (2021), 491-495. https://doi.org/10.14744/ejmi.2021.30687 |
